FINWIRES · TerminalLIVE
FINWIRES

TYO:4528

3 stories mentioning TYO:4528Updated just now

Every FINWIRES story that references TYO:4528, newest first.

Asia

Ono Pharmaceutical to Dispose of 47 Million Yen Treasury Shares Under Stock Compensation Plan

Ono Pharmaceutical (TYO:4528) board approved the disposal of 20,900 treasury shares totaling 47 million yen under its tenure-based restricted stock compensation plan.The board has also approved the disposal of 179,000 treasury shares totaling 402.7 million yen under its performance-based restricted stock compensation plan.The tenure-based shares were allocated to three directors, excluding outside directors, while performance-based shares were allocated to three directors, excluding outside directors, and 13 corporate officers, not on the company board, according to a Thursday filing on the Tokyo Stock Exchange.The disposal will be completed on July 10.Ono's shares fell 2% in recent trade.

TYO:4528
Asia

Jefferies Adjusts Ono Pharmaceutical's Price Target to 2,500 Yen From 1,750 Yen, Keeps at Hold

Ono Pharmaceutical (TYO:4528) has an average rating of hold and mean price target of 2,276.92 yen, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

TYO:4528
Asia

Ono Pharmaceutical's Attributable Profit Jumps 39% in Fiscal Year 2025

Ono Pharmaceutical's (TYO:4528) profit attributable to owners of the parent for fiscal year 2025 climbed 39% to 69.8 billion yen from 50 billion yen a year earlier.The pharmaceutical company's earnings per share increased to 148.41 yen from 106.41 yen a year ago, according to a Tokyo bourse filing on Friday.Revenue jumped 5.9% to 515.79 billion yen for the year ended March 31.Meanwhile, a final dividend of 40 yen per share, payable June 19, was also declared.For fiscal year 2026, the company expects attributable profit of 71 billion yen, basic EPS of 151.09 yen, and revenue of 455 billion yen. Ono Pharmaceutical also plans to keep per-share interim and year-end dividend payouts stable year over year at 40 yen for each period.

TYO:4528

Track with the FINWIRES app suite